| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |